🔎 Trials Near Me

Dachaigh › Aillse Prostata › Washington

Sgrùdaidhean clionaigeach Aillse Prostata ann an Washington

Tha 51 sgrùdaidhean airson Aillse Prostata a’ lorg phàirtichean aig làraichean ann an Washington.

Bailtean ann an Washington

Teacsa sgrùdaidh oifigeil (Beurla)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Washington, Fred Hutchinson Cancer Center, Seattle
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Providence Regional Cancer System-Aberdeen, Aberdeen
  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • Providence Regional Cancer System-Centralia, Centralia
  • agus 19 a bharrachd
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Valley Medical Center, Renton
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT03866382

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • Swedish Medical Center, Seattle
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 28 Sult 2026 · NCT06095089

Precision-Based Genomics in Prostate Cancer

  • University of Washington, Seattle
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Fir · Air ùrachadh 28 Sult 2026 · NCT04706663

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

  • Fred Hutchinson Cancer Research Center, Seattle
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 25 Sult 2026 · NCT06801236

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Spokane Urology ( Site 0035), Spokane
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06136650

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

  • Fred Hutchinson Cancer Center, Seattle
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 25 Sult 2026 · NCT07082920

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • Northwest Medical Specialties, PLLC, Bonney Lake
  • Northwest Medical Specialties, PLLC, Federal Way
  • Northwest Medical Specialties, PLLC, Gig Harbor
  • agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 24 Sult 2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Fred Hutchinson Cancer Research Center, Seattle
A’ fastadhÌre 2/3
Aoisean 18 gu 100 · Fir · Air ùrachadh 22 Sult 2026 · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • Northwest Medical Specialties, PLLC, Tacoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 22 Sult 2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Swedish Medical Center, Seattle
  • Northwest Medical Specialties, Tacoma
A’ fastadhÌre 3
Aoisean 18 gu 100 · Fir · Air ùrachadh 22 Sult 2026 · NCT06855277

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Sult 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Sult 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • VA Puget Sound Health Care System ( Site 0054), Seattle
  • Fred Hutchinson Cancer Center ( Site 0060), Seattle
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Sult 2026 · NCT06925737

PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

  • University of Washington Medical Center, Seattle
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Fir · Air ùrachadh 15 Sult 2026 · NCT04995198

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

  • University of Washington, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 14 Sult 2026 · NCT06111781

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • Fred Hutchinson Cancer Center, Seattle
  • FHCC at Northwest Hospital, Seattle
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 10 Sult 2026 · NCT05946213

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

  • Investigational Site Number: 400, Seattle
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 10 Sult 2026 · NCT05997615

Prostate Active Surveillance Study

  • Veterans Affairs Puget Sound Health Care System, Seattle
  • University of Washington, Seattle
A’ fastadhSgrùdadh amharc
Aoisean 21 agus nas sine · Fir · Air ùrachadh 2 Sult 2026 · NCT00756665

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Madigan Army Medical Center, Tacoma
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 45 gu 75 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06995898

Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 27 Lùna 2026 · NCT07698535

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Tacoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 26 Lùna 2026 · NCT07611110

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 25 Lùna 2026 · NCT05593497

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • University of Washington Medical Center, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 24 Lùna 2026 · NCT07745361

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

  • Fred Hutchinson Cancer Center, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 21 Lùna 2026 · NCT06844383

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Fred Hutchinson Cancer Center, Seattle
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 21 Lùna 2026 · NCT04221542

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Providence Regional Cancer System-Aberdeen, Aberdeen
  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • Providence Regional Cancer System-Centralia, Centralia
  • agus 19 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 19 Lùna 2026 · NCT04423211

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center, Seattle
  • Northwest Medical Specialties, PLLC - Tacoma, Tacoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Lùna 2026 · NCT06842498

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

  • Fred Hutchinson Cancer Center, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 14 Lùna 2026 · NCT04812366

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Fir · Air ùrachadh 12 Lùna 2026 · NCT04489719

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 11 Lùna 2026 · NCT06236139

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

  • Fred Hutchinson Cancer Center, Seattle
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 10 Lùna 2026 · NCT06067841

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
A’ fastadhÌre 2
Gach aois · Fir · Air ùrachadh 6 Lùna 2026 · NCT06145633

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Fir · Air ùrachadh 6 Lùna 2026 · NCT01050504

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

  • Fred Hutchinson Cancer Center, Seattle
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 31 Iuch 2026 · NCT06613100

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 21 Iuch 2026 · NCT06039371

Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
A’ fastadh
Aoisean 18 agus nas sine · Fir · Air ùrachadh 15 Iuch 2026 · NCT05918263

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Providence Regional Cancer System-Aberdeen, Aberdeen
  • FHCC Overlake, Bellevue
  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • agus 22 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 14 Iuch 2026 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • University of Washington, Fred Hutchinson Cancer Center, Seattle
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 9 Iuch 2026 · NCT05413421

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.